ValueMax Group Limited Announces Allotment and Issuance of New Shares Following Warrant Exercise
Key Highlights
- Allotment of New Shares: ValueMax Group Limited has increased its number of issued ordinary shares from 946,926,341 to 946,934,341 following the exercise of 8,000 warrants.
- Warrant Exercise Price: The warrants were exercised at S\$0.36 per share.
- Listing Date: The 8,000 new shares will be listed and quoted on the Singapore Exchange Securities Trading Limited (SGX-ST) on 5 June 2026.
- Outstanding Warrants: 870,968 warrants remain outstanding, each carrying the same exercise price of S\$0.36 and expiring at 5.00 p.m. on 14 September 2026.
Details for Investors
The Board of Directors of ValueMax Group Limited announced a corporate update regarding the company’s share capital structure. As a result of the exercise of 8,000 warrants at S\$0.36 each, the issued and outstanding ordinary shares of the company have increased by 8,000 shares. The total number of issued ordinary shares now stands at 946,934,341, excluding 100,000 treasury shares.
The newly issued shares will rank pari passu in all respects with the existing issued shares. This means the new shares confer the same rights as existing shares, including voting rights, dividends, and participation in any future distributions.
The new shares are set to be listed and quoted on the SGX on 5 June 2026, which allows the new shareholders to participate immediately in the trading and corporate actions of the company.
Important Information for Shareholders
- Potential Dilution: The exercise of warrants and subsequent issuance of new shares will have a minimal dilution effect on existing shareholders, as the increase represents less than 0.001% of the total share capital.
- Future Capital Inflows: With 870,968 warrants still outstanding (expiring 14 September 2026), ValueMax Group Limited could see further capital inflows of up to approximately S\$313,548 if all these warrants are exercised. This could potentially fund expansion, enhance liquidity, or be used for other corporate purposes.
- Price Sensitivity: The conversion of warrants at S\$0.36 per share may be seen as a positive indicator should the market price exceed this level, suggesting confidence from warrant holders in the company’s future prospects.
Shareholders are encouraged to monitor the company’s announcements for any significant changes in the number of shares outstanding, especially as the warrant expiry date approaches, as a higher rate of warrant conversions could indicate positive sentiment and additional capital inflow.
Conclusion
While the current warrant exercise is relatively small in scale, it demonstrates ongoing interest in the company’s equity and sets a precedent for future capital-raising activities through further warrant exercises. Investors should keep a close eye on the remaining outstanding warrants, as their eventual conversion could impact the company’s share structure and capital base.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own research or consult financial advisors before making investment decisions related to ValueMax Group Limited.
华文版本
ValueMax集团有限公司因认股权证行使宣布配发新股
主要亮点
- 新股配发：ValueMax集团有限公司在8,000份认股权证行使后，已将发行普通股数量从946,926,341股增加至946,934,341股。
- 认股权证行使价：每股行使价为新元0.36。
- 上市日期：8,000股新股将于2026年6月5日在新加坡证券交易所(SGX-ST)上市及报价。
- 未行使认股权证：目前仍有870,968份认股权证尚未行使，每份行使价为新元0.36，将于2026年9月14日17:00到期。
投资者须知
ValueMax集团有限公司董事会宣布，因8,000份认股权证以每股新元0.36的价格被行使，公司已增加8,000股普通股。截至目前，已发行普通股总数为946,934,341股（不包括100,000股库藏股）。
新发行的股份在所有方面与现有已发行股份享有同等权利，包括投票权、分红及未来任何分配的参与权。
新股将于2026年6月5日在新交所上市，届时新股持有人可立即参与公司股票交易及相关企业行动。
股东需关注的重要信息
- 潜在稀释：此次认股权证行使及新股发行对现有股东的稀释影响极小，增发股份占总股本比例不到0.001%。
- 未来资本流入：目前尚有870,968份认股权证未行使（到期日2026年9月14日），若全部行使，公司有望获得约新元313,548的资本流入，为扩展业务、增强流动性或其他公司用途提供资金。
- 价格敏感性：认股权证以每股新元0.36转股，若市场价高于该水平，或显示认股权证持有人对公司前景有信心，可能对股价形成积极影响。
建议股东关注公司公告，特别是在认股权证到期前，任何新增股份变化都可能反映市场情绪及额外资本流入。
结语
虽然本次认股权证行使规模较小，但显示出市场对公司权益的持续兴趣，并为未来更多认股权证行使及资本募集活动奠定基础。投资者应密切关注剩余认股权证的行使情况，其最终转股将影响公司股本结构和资本基础。
免责声明：本报道仅供参考，并不构成任何投资建议。投资者在做出与ValueMax集团有限公司相关的投资决策前，应自行研究或咨询专业财务顾问。
